Contents
The third phase of clinical trials for the coronavirus vaccine began in Kansas on September 24th. If all goes well, the vaccine could be available to the general public as early as December.
Checkout this video:
When will the Phase 3 vaccine start in Kansas?
The Phase 3 vaccine clinical trial will start enrolling adult volunteers in Kansas in late July or early August, 2020. The trial is expected to take about two years to complete.
What is the Phase 3 vaccine?
The Phase 3 vaccine is the final stage of the human clinical trial process for a vaccine. This stage usually starts after the vaccine has been proven to be safe and effective in Phase 1 and 2 clinical trials.
In Phase 3 clinical trials, the vaccine is given to a large group of people (usually several thousand) to confirm its effectiveness, monitor any side effects, and collect more information on rarer side effects that might not have been seen in earlier trials.
In the United States, vaccines typically go through 3 phases of testing before they are approved by the FDA for general use:
Phase 1: A small group of people (20-80) receive the vaccine to evaluate its safety and see if it causes any side effects.
Phase 2: A larger group of people (100-300) receive the vaccine to further assess its safety and effectiveness. In some cases, Phase 2 trials are divided into two parts. In Part A, a small group of people receive the vaccine to evaluate its safety and immunogenicity (ability to produce an immune response). In Part B, a larger group of people are vaccinated to determine if the vaccine is effective at preventing disease.
Phase 3: The vaccine is given to thousands of people to confirm its effectiveness, monitor any side effects, and collect more information on rarer side effects that might not have been seen in earlier trials.
Vaccines usually take years—sometimes even decades—to develop. So even though we are still in Phase 3 of testing for a COVID-19 vaccine, this doesn’t mean that the process has been rushed.
What is the process for Phase 3?
The Phase 3 process is when the vaccine is given to a large group of people to test for safety and effectiveness. This is the final stage before the vaccine is submitted for FDA approval.
In order to be eligible for the vaccine, you must be a Kansas resident and 18 years of age or older. You will also need to sign up for the waiting list.
The waiting list will be open to everyone who wants to receive the vaccine, regardless of whether they are in a high-risk group. The vaccine will be given on a first-come, first-serve basis.
There is no specific date for when Phase 3 will start in Kansas. It is dependent on when the vaccines become available from the manufacturers.
How long will Phase 3 last?
As of September 13, 2020, vaccinators in Kansas have only vaccinated people in Phase 1 and 2 of the state’s vaccination plan.
The Kansas Department of Health and Environment (KDHE) has not yet announced a start date for Phase 3 vaccinations. When the KDHE does announce a start date for Phase 3 vaccinations, The us will update this article.
Phase 3 of the KDHE’s vaccination plan will vaccinate people who are not in Phase 1 or 2. This includes people who are ages 16-64 with underlying medical conditions that put them at risk for severe illness from COVID-19, as well as other essential workers not already vaccinated in Phase 1 or 2.
What are the benefits of the Phase 3 vaccine?
The benefits of the Phase 3 vaccine are that it is more effective and has fewer side effects.
